Skip to main content
. 2025 Aug 22;5(1):e191. doi: 10.1017/ash.2025.10101

Table 2.

Treatment outcomes

Outcome Short-course group (n = 33) Long-course group (n = 19) p-value
Treatment failure—n (%) 5 (15.2%) 3 (15.8%) 1.000
C. Difficile infection within 30 days—n (%) 0 (0%) 0 (0%)
Hospital readmission within 30 days—n (%) 1 (3.0%) 6 (31.6%) .007
UTI-related readmission—n (%) 0 (0%) 0 (0%)
Telephone encounters within 30 days of discharge—n (%) 13 (39.4%) 9 (47.4%) .575
Duration of IV beta-lactam treatment (days) – median (IQR) 3 (3–3) 3 (2–4) .312
Total antibiotic duration (days) – median (IQR) 3 (3–3) 6 (5–7) < .001
Discharge antibiotics prescribed—n (%) 2 (6.1%) 9 (47.4%) < .001
Hospital length of stay (days) – median (IQR) 3.66 (2.42–8.32) 3.94 (2.92–6.66) .932